Mae meddyginiaethau, gan gynnwys Sarilumab a Tocilizumab, sydd wedi dod ar gael drwy’r Gronfa Triniaethau Newydd i drin arthritis ac arthritis gwynegol, bellach hefyd ar gael yn ddi-oed i’r GIG eu defnyddio i helpu i reoli COVID-19.
Medicines including Sarilumab and Tocilizumab, made available via the New Treatment Fund to treat arthritis and rheumatoid arthritis, are also now able to be rapidly deployed by the NHS for use in the management of COVID-19.